Did you know that antibiotic resistance is one of the biggest public health threats of our time? And
yet it is often overlooked by healthcare companies and investors. Hi, I am Camille Rigaud from Kieger.
Every year, approximately 700,000 people die from antibiotic resistance and, by 2050, this number
could reach 10 million if no action is taken according to the UN. Without effective antibiotics to treat or prevent infections, common surgical procedures such as a hip replacement or a C-section, for example, could become too risky to perform. The antibiotic arsenal has been dwindling, with the number of new antibiotics approved in the US declining, as it has also elsewhere in the world.
Large pharma companies have left this business due to unattractive economics and small biotech
firms have been trying to fill the gap. However, many struggle to get funding and many have filed for
bankruptcy or were sold off.
We need more industry commitments as well as new incentive mechanisms to drive the development
of novel and effective antibiotics. Covid is a reminder of the threat of new infectious diseases and that the world needs to be better prepared for the next threat.
Rarely are health inequalities more apparent than when walking around San Francisco during the J.P. Morgan Healthcare Conference. In our chart of the month, Raphael Oesch (Portfolio Manager), takes a look at the statistics and discusses some of the reasons behind the figures.
We recently attended the 41st J.P. Morgan Healthcare Conference in San Francisco, which took place from January 9th to January 12th 2023. Our overall conclusion from the conference is that the industry remains in good shape. The key themes that emerged during the week from a devices and services perspective were, the rise of value-based care and innovation & digitalisation. However, it also became clear that the macroeconomic environment is still the dominant force behind (sub) sector performance.
Day after day currently feels like a roller coaster ride, going up because of better than hoped for CPI numbers, down because of looming recession fears, and back up because of a less hawkish FED speech. Are we there yet? What do you think?